| Abstrakt: |
A recent study conducted by researchers at the First Affiliated Hospital of Anhui University of Chinese Medicine in China has explored factors associated with optimal serum non-ceruloplasmin bound copper (NCBC) levels in patients with Wilson's disease (WD). The study aimed to develop a predictive model to guide lifelong therapy and delay disease progression. The researchers collected clinical data from 144 patients and identified several independent risk factors for serum NCBC levels, including age of diagnosis, clinical classification, laminin liver stiffness measurement, and copper to zinc ratio in 24-hour urinary excretion. The study concluded that the predictive nomogram model can be used in clinical practice to improve the clinical prognosis of WD. [Extracted from the article] |
